Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Venous endothelial cells are molecularly and functionally distinct from their arterial counterparts. Although veins are often considered the default endothelial state, genetic manipulations can modulate both acquisition and loss of venous fate, suggesting that venous identity is the result of active transcriptional regulation. However, little is known about this process. Here we show that BMP signalling controls venous identity via the ALK3/BMPR1A receptor and SMAD1/SMAD5. Perturbations to TGF-β and BMP signalling in mice and zebrafish result in aberrant vein formation and loss of expression of the venous-specific gene Ephb4, with no effect on arterial identity. Analysis of a venous endothelium-specific enhancer for Ephb4 shows enriched binding of SMAD1/5 and a requirement for SMAD binding motifs. Further, our results demonstrate that BMP/SMAD-mediated Ephb4 expression requires the venous-enriched BMP type I receptor ALK3/BMPR1A. Together, our analysis demonstrates a requirement for BMP signalling in the establishment of Ephb4 expression and the venous vasculature.

Original publication

DOI

10.1038/s41467-019-08315-w

Type

Journal article

Journal

Nature communications

Publication Date

28/01/2019

Volume

10

Addresses

Ludwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.

Keywords

Veins, Endothelial Cells, Animals, Animals, Genetically Modified, Mice, Transgenic, Mice, Knockout, Zebrafish, Receptor, EphB4, Transforming Growth Factor beta, Zebrafish Proteins, Bone Morphogenetic Proteins, Signal Transduction, Gene Expression Regulation, Developmental, Smad1 Protein, Smad5 Protein, Bone Morphogenetic Protein Receptors, Type I